ABSTRACT
Transfection efficiency of the immortalized human breast epithelial cell line MCF-10A remains an issue that needs to be resolved. In this study, it was aimed to deliver a recombinant DNA (pCMV-Azu-GFP) to the MCF-10A cells by the magnetofection method using magnetic nanoparticles (MNPs) and a simple magnet to accelerate the DNA delivery. Surface positively modified silica-coated iron oxide MNPs (MSNP-NH2) were produced and characterized via TEM, FTIR, and DLS analyses. The recombinant DNA (rDNA) was obtained by the integration of codon-optimized azurin to produce a fusion protein. Then, rDNA cloned in Escherichia coli cells was validated by sequence analysis. The electrostatically conjugated rDNA on MSNP-NH2 with an enhancer polyethyleneimine (PEI) was studied by agarose gel electrophoresis and the optimum conditions were determined to apply to the cell. A dose-dependent statistical difference was observed on treated cells based on the MTS test. The expression of the fusion protein after magnetofection was determined using laser scanning confocal microscope imaging and western blot analysis. It was observed that the azurin gene could be transferred to MCF-10A cells by magnetofection. Thus, when the azurin gene is used as a breast cancer treatment agent, it can be expressed in healthy cells without toxic effects.
Subject(s)
Aortic Valve/surgery , Heart Valve Prosthesis/standards , Mitral Valve/surgery , Humans , Male , Middle Aged , Time Factors , Treatment OutcomeABSTRACT
Reel syndrome is a rare form of Twiddler's syndrome and is characterized by rotation of permanent pacemaker on its transverse axis and rolling of the electrode around the generator. An 83-year-old man with severely impaired mental status, agitation, and uncontrolled movement of extremities underwent pacemaker implantation for symptomatic atrial fibrillation. The pacemaker generator was fixed to the pectoral fascia with nonabsorbable ligatures. On the next day, failure to capture the ventricle was noted. Fluoroscopic examination showed coiling of the electrode around the generator. During urgent intervention, the ligature of the generator was observed to be released from the pectoral fascia. The pacemaker lead was not damaged; therefore, the same lead was re-implanted, connected to the generator, and carefully fixed to the pectoral fascia. The patient showed rapid clinical improvement together with his mental status. No abnormality was detected during three months of follow-up. Patients with impaired consciousness, children, and older persons require a close follow-up because of their propensity to this serious and life-threatening complication.